Momenta pharmaceuticals, inc. (MNTA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic

-284,767

-290,055

-211,600

-217,357

-173,273

-176,061

-154,057

-136,945

-103,968

-88,096

-60,316

-44,672

-28,750

-21,003

-91,706

-104,212

-85,448

-83,313

-70,130

-69,181

-93,115

-98,600

-112,680

-108,961

-111,654

-108,408

-96,024

-96,464

-77,782

-58,648

-42,224

43,936

118,368

180,356

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization of property and equipment

6,486

11,610

15,199

16,260

13,990

9,917

8,879

8,666

8,543

8,023

6,593

6,842

6,977

7,600

7,521

7,435

7,394

7,594

7,773

7,963

7,863

7,637

8,226

7,154

7,189

7,108

6,373

7,172

6,926

6,419

4,479

4,674

4,295

4,137

0

0

0

Share-based compensation expense

23,779

22,430

14,875

18,312

19,822

21,222

19,990

14,780

14,198

16,127

19,875

19,898

20,297

18,322

19,409

19,026

20,653

11,440

9,866

8,709

5,758

13,594

13,981

13,737

13,402

12,822

12,808

13,202

13,329

13,712

13,382

12,950

12,626

11,138

0

0

0

Amortization of premium on investments

1,168

1,728

1,797

1,662

1,093

438

256

-134

-204

-167

-319

-277

-342

-595

-920

-1,249

-1,369

-1,383

-1,294

-1,276

-1,619

-2,162

-2,803

-3,281

-3,573

-3,575

-3,738

-3,820

-3,624

-3,288

-2,640

-2,180

-1,945

-1,677

0

0

0

Amortization of intangibles

1,154

1,153

1,153

1,153

1,153

1,153

1,153

1,154

1,153

1,153

1,154

1,207

1,552

1,529

1,505

1,429

1,061

1,061

1,061

1,061

1,061

1,061

1,061

1,061

1,061

1,061

1,061

1,060

1,061

1,061

0

0

0

-

-

-

0

Gain on disposal of assets

323

750

902

541

6

-510

-684

-697

-137

-61

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

0

0

0

-

-

-

-

Changes in operating assets and liabilities:
Collaboration receivable

13,606

-3,358

-8,165

-8,831

-1,767

-3,677

-498

-11,577

-21,791

-55,194

0

0

0

-

-

-265

9,741

10,849

1,967

24,146

784

-6,172

1,247

5,469

2,408

2,284

1,451

-16,253

-16,976

-17,360

-79,788

-65,451

-59,982

-26,314

0

0

0

Unbilled revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,289

1,067

2,513

2,613

4,161

414

119

-1,965

-1,367

-1,681

-815

-2,500

0

0

0

Prepaid expenses and other current assets

3,779

4,227

4,307

2,408

1,140

-573

-1,209

-2,435

1,387

2,098

0

0

0

-

-

1,554

1,097

14

-372

-3

-292

64

-950

-1,807

-39

-1,552

1,087

1,507

567

2,406

554

186

896

754

0

0

0

Other long-term assets

-2,979

-4,225

-2,084

-4,467

-1,969

703

-220

-337

-1,216

-1,229

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

-6,903

4,831

-1,115

2,349

4,487

-1,158

-6,528

-4,359

-1,627

7,446

0

0

0

-

-

10,244

-2,106

-3,380

2,569

-2,090

640

1,126

-3,044

1,234

1,211

2,727

-527

-1,091

-5,778

-1,129

4,166

611

4,693

315

0

0

0

Accrued expenses

39,260

43,413

7,706

-741

-6,445

-6,229

-5,046

-14,017

-6,046

-6,253

0

0

0

-

-

-1,657

8,920

14,151

2,219

6,136

-2,713

-1,099

134

1,655

2,725

1,806

3,825

-1,196

465

510

-2,019

3,748

1,147

33

0

0

0

Accrued restructuring

-1,522

-3,201

-8,417

1,111

1,556

3,235

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration liabilities

-804

-598

1,097

-1,685

-5,118

-4,537

-10,702

-14,402

-19,315

-23,637

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-2,706

-3,855

-35,110

-35,020

-34,031

-33,438

-52,611

-53,103

-53,968

-5,015

0

0

0

-

-

32,465

34,308

-9,015

-502

1,053

2,636

3,282

-3,770

-3,831

-3,997

-3,979

-4,257

-4,644

-4,982

27,931

28,649

29,443

30,271

-2,149

0

0

0

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Lease incentive

-

-

-

-

-

-

-

-

-

4,051

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

9,932

8,429

15,758

3,572

9,828

15,182

20,669

33,970

3,274

-66

0

0

0

-

-

-457

-428

-58

0

0

0

-

-

-

105

-18

30

45

138

482

0

0

0

-

-

-

-

Other long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

714

192

-482

-572

-566

-515

-461

105

214

258

300

545

540

526

517

0

0

0

-

-

-

-

Net cash used in operating activities

-231,825

-204,802

-201,031

-191,854

-155,029

-155,590

-159,601

-142,396

-130,282

-29,085

54,268

56,141

58,110

8,989

-60,488

-35,774

-29,016

-71,515

-48,264

-70,577

-73,535

-65,168

-90,907

-89,704

-91,490

-86,832

-79,226

-62,575

-48,249

8,999

76,394

152,812

223,752

213,725

0

0

0

Cash Flows from Investing Activities:
Purchases of property and equipment

2,496

1,776

2,162

3,365

5,601

9,019

14,508

18,119

18,982

17,127

12,016

7,624

5,769

5,609

6,127

6,412

5,069

4,068

5,200

5,002

6,396

8,360

8,797

10,574

11,151

9,450

7,438

7,222

8,090

15,491

17,532

16,320

14,423

8,699

0

0

0

Proceeds from disposal of equipment

1,879

3,148

4,355

3,825

2,720

1,447

351

338

279

267

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of marketable securities

338,720

274,581

327,103

327,270

293,006

202,525

276,036

325,278

520,938

524,888

461,395

407,418

288,024

360,008

389,078

559,615

509,347

405,673

324,504

115,565

93,138

111,809

120,612

141,886

155,517

229,969

258,846

348,812

434,543

515,088

562,032

578,768

603,318

551,272

0

0

0

Proceeds from maturities of marketable securities

316,557

315,174

342,165

347,966

267,486

308,178

309,950

432,051

435,619

420,669

413,312

309,559

387,700

445,665

490,594

415,299

335,812

245,907

139,906

148,261

168,854

195,342

234,894

272,918

254,385

294,183

289,390

371,544

489,805

523,572

520,286

494,941

381,228

302,415

0

0

0

Proceeds from sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,822

0

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-22,780

41,965

17,255

21,156

-28,401

98,081

19,757

88,992

-104,022

-121,079

-60,099

-105,483

93,907

80,048

95,389

-150,728

-178,604

-163,834

-189,798

27,694

69,320

75,173

105,485

120,458

87,717

58,586

26,928

18,932

50,594

-7,407

-64,178

-111,311

-247,677

-268,720

0

0

0

Cash Flows from Financing Activities:
Payment of financing fees related to public offering

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash Flows from Financing Activities:
Net proceeds from issuance of common stock

-

-

-

-

-

-

-

-

-

64,090

64,090

64,090

14,441

0

0

0

30,838

64,503

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under stock plans

22,795

16,489

5,419

11,281

23,512

29,272

28,525

23,839

13,665

10,258

10,673

8,971

6,765

2,407

2,456

3,984

22,214

24,567

23,974

22,572

4,343

3,273

3,167

5,651

5,995

5,022

4,532

1,830

2,286

2,153

2,761

3,624

5,503

5,546

0

0

0

Net cash provided by financing activities

267,018

260,969

223,205

229,067

241,298

247,058

28,525

23,839

63,314

74,348

74,762

73,060

20,140

1,341

1,391

2,919

199,443

235,461

253,173

251,771

56,313

21,578

3,167

5,651

5,995

5,022

4,532

1,830

2,286

2,153

2,210

2,974

3,924

3,559

0

0

0

Payments on financed leasehold improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

258

0

0

0

Principal payments on capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,729

0

0

0

Net decrease in cash, cash equivalents and restricted cash

12,413

98,132

39,429

58,369

57,868

189,549

-111,319

-29,565

-170,990

-75,816

68,931

23,718

172,157

90,378

36,292

-183,583

-8,177

112

15,111

208,888

52,098

31,583

17,745

36,405

2,222

-23,224

-47,766

-41,813

4,631

3,745

14,426

44,475

-20,001

-51,436

0

0

0

Non-Cash Activities:
Purchases of property and equipment included in accounts payable and accrued expenses

1,450

1,051

-793

-291

-907

43

-1,086

771

1,405

1,228

4,210

1,750

1,986

935

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing fees in accounts payable

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable due from broker for issuance of common stock under ATM facility

-

-

-

-

-

-

-

-

-

-

-

-

4,072

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable due from stock option exercises

0

-

-

-

0

-

-

-

774

93

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impact of adopting ASU 2016-09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

91

0

0

0

Accounting Standards Update 2014-09
Impact from adoption of ASUs

-

-

-

-

-

5,511

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-